267 related articles for article (PubMed ID: 25845850)
21. Myeloid cell leukemia-1 promotes epithelial-mesenchymal transition of human gastric cancer cells.
Lee WS; Kim N; Park YR; Oh HH; Myung E; Kim SH; Yu HM; Kim MY; Oak CY; Chung CY; Park HC; Myung DS; Cho SB; Joo YE
Oncol Rep; 2015 Aug; 34(2):1011-6. PubMed ID: 26058661
[TBL] [Abstract][Full Text] [Related]
22. Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer.
Gong J; Wang Y; Jiang B; Xu B; Hu C
Cancer Manag Res; 2019; 11():4075-4084. PubMed ID: 31118815
[No Abstract] [Full Text] [Related]
23. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
[TBL] [Abstract][Full Text] [Related]
24. High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diffuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2).
Wang Y; Tan J; Wu H; Yi C
Med Sci Monit; 2019 May; 25():3860-3868. PubMed ID: 31124542
[TBL] [Abstract][Full Text] [Related]
25. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer.
Murai T; Yamada S; Fuchs BC; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2014 Jun; 109(7):684-9. PubMed ID: 24453058
[TBL] [Abstract][Full Text] [Related]
27. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract][Full Text] [Related]
28. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
29. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
[TBL] [Abstract][Full Text] [Related]
30. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
32. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.
Wang L; Wu Y; Lin L; Liu P; Huang H; Liao W; Zheng D; Zuo Q; Sun L; Huang N; Shi M; Liao Y; Liao W
Int J Cancer; 2013 Sep; 133(6):1419-30. PubMed ID: 23457029
[TBL] [Abstract][Full Text] [Related]
33. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells.
Zhu C; Li J; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Wang M; Zhang Z; Qin C; Hua L; Yin C; Shao P
Mol Cell Biochem; 2013 Jul; 379(1-2):69-75. PubMed ID: 23591597
[TBL] [Abstract][Full Text] [Related]
34. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
35. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
36. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
37. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
39. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
40. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
